ANTHONY M MAGLIOCCO, MD
Medical Practice at Usf Magnolia Dr, Tampa, FL
License number
Florida ME110468
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
12902 Usf Magnolia Dr, Tampa, FL 33612
Phone
(813) 745-4673
(813) 745-8495 (Fax)
(813) 745-8495 (Fax)
Personal information
See more information about ANTHONY M MAGLIOCCO at radaris.comName
Address
Phone
9038 Hernando St, Weeki Wachee, FL 34613
Professional information
See more information about ANTHONY M MAGLIOCCO at trustoria.com
Dr. Anthony M Magliocco, Tampa FL - MD (Doctor of Medicine)
Dr. Anthony M Magliocco, Tampa FL - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology, Anatomic & Clinical Pathology
Address:
Moffitt Cancer Center
12902 Usf Magnolia Dr, Tampa 33612
(813) 745-4673 (Phone), (813) 449-8210 (Fax)
12902 Usf Magnolia Dr, Tampa 33612
(813) 745-4673 (Phone), (813) 449-8210 (Fax)
Languages:
English
Hospitals:
Moffitt Cancer Center
12902 Usf Magnolia Dr, Tampa 33612
H. Lee Moffitt Cancer Center and Research Institute I.
12902 Usf Magnolia Dr, Tampa 33612
12902 Usf Magnolia Dr, Tampa 33612
H. Lee Moffitt Cancer Center and Research Institute I.
12902 Usf Magnolia Dr, Tampa 33612
Philosophy:
Dr. Magliocco's research focuses on elucidating the molecular mechanisms of cancer progression and the development of drug resistance with emphasis on breast cancer. In addition, he works on the development of clinical markers of radiotherapy resistance using cervical cancer as a model system. His clinical interests focus on molecular biomarker development for improving cancer treatment. In addition he has special expertise in breast and gynecological pathology.
Education:
Medical School
MD, University Of Alberta
Graduated: 1987
Resident, University Of Calgary-Anatomical Pathology
Graduated: 1991
Fcap Fellow, College Of American Pathologists-Pathology
Graduated: 1992
Frcpc Fellow, Royal College Of Physicians and Surgeons-Anatomical Pathology
Postdoctoral Fellow, Fox Chase Cancer Center-Molecular Surgical Pathology
MD, University Of Alberta
Graduated: 1987
Resident, University Of Calgary-Anatomical Pathology
Graduated: 1991
Fcap Fellow, College Of American Pathologists-Pathology
Graduated: 1992
Frcpc Fellow, Royal College Of Physicians and Surgeons-Anatomical Pathology
Postdoctoral Fellow, Fox Chase Cancer Center-Molecular Surgical Pathology
Identification Of Cancer Patients Likely To Benefit From Radiation Therapy
Identification Of Cancer Patients Likely To Benefit From Radiation Therapy
US Patent:
2013034, Dec 26, 2013
Filed:
Dec 2, 2011
Appl. No.:
13/990727
Inventors:
Mark Gustavson - Greensboro NC, US
Jason Christiansen - Glastonbury CT, US
Anthony Martin Magliocco - Tampa FL, US
Jason Christiansen - Glastonbury CT, US
Anthony Martin Magliocco - Tampa FL, US
Assignee:
UTI Limited Partnership - Alberta CA
HistoRx, Inc. - Branford CT
HistoRx, Inc. - Branford CT
International Classification:
G01N 33/68
US Classification:
435 723
Abstract:
Disclosed herein are methods of identifying suitable patients for postoperative radiotherapy based on the discovery that the quantification of ER, beyond simple positive/negative characterization, can provide valuable predictive information for the treatment of cancer, specifically breast cancer, and more particularly may predict a group more likely to respond to RT and spare patients from a potentially harmful treatment. Furthermore, the true quantification of ER expression provides a continuous recurrence risk assessment for patients being treated with tamoxifen, and therefore the standardization of the data across sites and imaging platforms significantly reduces the misclassification of patients when compared to the current standard by which ER expression is determined.